尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the complete record of transactions filed by Glenn Jeffrey S, 董事. Insider active across 1 company, notably Eiger BioPharmaceuticals, Inc.. Aggregated, 2 disclosures have been published. Split: 1 buy · 0 sell. Total volume traded: €121k. Activity tracked since 11 March 2022. The latest transaction was filed on 22 December 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Glenn Jeffrey S is a Board Member at Eiger BioPharmaceuticals, Inc. He brings significant expertise in the biopharmaceutical sector, contributing to the strategic direction of the company. His role involves overseeing operations and ensuring compliance with regulatory standards. Glenn plays a key role in strategic decisions that shape the future of the company.